Comparative risk perception of the monkeypox outbreak and the monkeypox vaccine

Abstract

AbstractBased on survey data collected from a nationally representative sample (N = 1,000), this study applies the psychometric paradigm to demonstrate that the American public perceived the monkeypox outbreak as a more dreaded risk than the monkeypox vaccine, but they also viewed the monkeypox vaccine as a more unknown risk. These perceptions influenced their overall risk judgment toward the monkeypox outbreak, support for public health responses and government assistance measures, and likelihood to get vaccinated. Contributing to research on risk perception, these findings indicate that the dread and unknown dimensions offer a more intricate assessment of risk perception beyond perceived susceptibility and perceived severity. Guiding risk communication practice, these results suggest that it is important to highlight to the public that the monkeypox vaccine is a mature technology and getting vaccinated before exposure provides the best protection for high‐risk populations.